Skip to main content
Premium Trial:

Request an Annual Quote

US FDA Hires Former ProtoGene Scientist, Felix Frueh, as Associate Director of Genomics

Premium

BioArray News has learned that the US Food and Drug Administration has hired Felix Frueh for the apparently new position of associate director of genomics within the Center for Drug Evaluation and Research.

Frueh, reached Tuesday by phone, confirmed that he had joined the agency three weeks ago but deferred comment other than to say he was excited about the opportunity.

Prior to joining the FDA, Frueh, 37, founded a Gaithersburg, Md., consultancy, Stepoutside Consulting, whose website describes its mission as “helping small and medium-size European biotechnology companies establish a US market presence.” The company, which offers a variety of services including regulatory consulting, was sold in May to DNA Bridges, a consultancy with offices in San Francisco and Wilmington, Del.

Frueh arrives at the FDA at a time when the agency is preparing to finalize the pharmacogenomics draft guidance document (see BAN 11/19/2003), which was released for comment in November 2003.

He will likely head the Interdisciplinary Pharmacogenomics Review Group, or IPRG, which will oversee voluntary pharmacogenomics data submissions.

The FDA is discussing the pharmacogenomics draft guidance documents this week at the Biotechnology Industry Organization’s annual convention in San Francisco, and next week at the Drug Information Association’s annual meeting in Washington, DC (June 13-17).

FDA officials did not return BioArray News requests for comment in time for the publishing deadline.

Frueh, previously was a senior scientist at ProtoGene Laboratories, a now defunct microarray developer.

Additionally, he has been an assistant professor at Georgetown University Medical Center.

—MOK

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.